Find a Clinical Trial

Find a Clinical Trial

Use the abbreviation for your state (ie. FL, TX, NV)
Search by practice name, trial titles, indicators and specific disease types.

Mesothelioma

Clinical Trial at: Florida Cancer Affiliates - Ocala

Double blind, randomised, multicentre, phase II/III study of nintedanib in combination with pemetrexed/cisplatin followed by continuing nintedanib monotherapy versus placebo in combination with pemetrexed/cisplatin followed by continuing placebo monotherapy for the treatment of patients with unresectable malignant pleural mesothelioma (1199.93)

  • Details

ClinicalTrials.gov ID: NCT01907100
Diagnosis Type: NA
USOR Number: 15175

  • Practice Details

3130 SW 32nd Street
Ocala, Florida 34471
110.44 mi. away
P: (352) 732-4032

More Details View Practice Page

Lung Cancer

Clinical Trial at: Florida Cancer Affiliates - Ocala

A Dose Frequency Optimization, Phase IIIB/IV Trial of Nivolumab 240 mg Every 2 Weeks vs Nivolumab 480 mg Every 4 Weeks in Subjects with Advanced or Metastatic Non-small Cell Lung Cancer who Received Up to 12 Months of Nivolumab at 3 mg/kg or 240 mg Every 2 Weeks(CheckMate 384- CA209384)

  • Details

ClinicalTrials.gov ID: NCT02713867
Diagnosis Type: NA
USOR Number: 15203

  • Practice Details

3130 SW 32nd Street
Ocala, Florida 34471
110.44 mi. away
P: (352) 732-4032

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Florida Cancer Affiliates - Ocala

A Phase 2, Open-label, Single Agent, Multi-Center Study to Evaluate the Efficacy and Safety of a Pan-FGFR Tyrosine Kinase Inhibitor INCB054828 in Patients with Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations (INCB 54828-201)

  • Details

ClinicalTrials.gov ID: NCT02872714
Diagnosis Type: NA
USOR Number: 15228

  • Practice Details

3130 SW 32nd Street
Ocala, Florida 34471
110.44 mi. away
P: (352) 732-4032

More Details View Practice Page

Biliary Cancer

Clinical Trial at: Florida Cancer Affiliates - Ocala

A Phase 2, Open-Label, Single Arm, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects with Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Including FGFR2 Translocations Who Failed Previous Therapy (INCB 54828-202)

  • Details

ClinicalTrials.gov ID: NCT02924376
Diagnosis Type: NA
USOR Number: 16066

  • Practice Details

3130 SW 32nd Street
Ocala, Florida 34471
110.44 mi. away
P: (352) 732-4032

More Details View Practice Page

Lymphomas

Clinical Trial at: Florida Cancer Affiliates - Ocala

A PHASE 3B RANDOMIZED STUDY OF LENALIDOMIDE (CC-5013) PLUS RITUXIMAB MAINTENANCE THERAPY FOLLOWED BY LENALIDOMIDE SINGLE-AGENT MAINTENANCE VERSUS RITUXIMAB MAINTENANCE IN SUBJECTS WITH RELAPSED/REFRACTORY FOLLICULAR, MARGINAL ZONE OR MANTLE CELL LYMPHOMA (CC-5013-NHL-008)(MAGNIFY)

  • Details

ClinicalTrials.gov ID: NCT01996865
Diagnosis Type: Non-Hodgkins
USOR Number: 13064

  • Practice Details

3130 SW 32nd Street
Ocala, Florida 34471
110.44 mi. away
P: (352) 732-4032

More Details View Practice Page

Lung Cancer

Clinical Trial at: Florida Cancer Affiliates - Ocala

CA209-817: A Phase IIIb/IV Safety and Efficacy Trial of Flat Dose Nivolumab in Combination with Ipilimumab in Participants with Non-Small Cell Lung Cancer

  • Details

ClinicalTrials.gov ID: NCT02869789
Diagnosis Type: NSCLC
USOR Number: 16156

  • Practice Details

3130 SW 32nd Street
Ocala, Florida 34471
110.44 mi. away
P: (352) 732-4032

More Details View Practice Page

Pages